HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Caselli, E. Articles by Luca, D. D. Search for Related Content PubMed PubMed Citation Articles by Caselli, E. Articles by Luca, D. D. Agricola Articles by Caselli, E. Articles by Luca, D. D.

Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection

¹ Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Via Borsari 46, 44100 Ferrara, Italy
² Institute of Microbiology, University of Brescia Medical School, Brescia, Italy

Correspondence
Dario Di Luca
dil{at}unife.it

ORF50, an immediate-early gene of human herpesvirus-8 (HHV-8), encodes a transactivating protein necessary for virus reactivation and lytic replication. ORF50 was reported recently to synergize with human immunodeficiency virus type 1 (HIV-1) tat at a post-transcriptional level. To study the effects of these molecular interactions on HIV replication and biology, cellular clones stably transformed with ORF50 were obtained by transfection of cell lines of different origin. These clones were infected subsequently with HIV. Experiments showed that ORF50 enhances HIV replication in T and B cells (Jurkat and BC-3 cells) and induces susceptibility and transient permissiveness in non-susceptible glial (A172) cells. Upregulation of viral receptors and co-receptors did not account for increased sensitivity to HIV infection and therefore the action of ORF50 might be modulated by the intracellular environment. Interestingly, non-susceptible cells transformed with ORF50 showed transient production of HIV particles that could spread to adjacent cells by direct contact. These findings show that HHV-8 ORF50 has an enhancing effect on HIV replication in vitro and suggest that the two viruses might interact in co-infected patients.

This article has been cited by other articles:

				M Comar, P D'Agaro, C Campello, A Poli, J P Breinholt III, J A Towbin, and M Vatta Human herpes virus 6 in archival cardiac tissues from children with idiopathic dilated cardiomyopathy or congenital heart disease J. Clin. Pathol., January 1, 2009; 62(1): 80 - 83. [Abstract] [Full Text] [PDF]

				A. Lisco, M. Barbierato, J. R. Fiore, P. Gasperini, A. Favia, A. Volpe, M. Chironna, G. Pastore, L. Chieco-Bianchi, and M. L. Calabro Pregnancy and Human Herpesvirus 8 Reactivation in Human Immunodeficiency Virus Type 1-Infected Women J. Clin. Microbiol., November 1, 2006; 44(11): 3863 - 3871. [Abstract] [Full Text] [PDF]

				E. Caselli, M. Galvan, E. Cassai, A. Caruso, L. Sighinolfi, and D. Di Luca Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells Blood, October 15, 2005; 106(8): 2790 - 2797. [Abstract] [Full Text] [PDF]